Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pivot Pharmaceuticals Inc (PVOTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 38,684
  • Shares Outstanding, K 75,850
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,280 K
  • 36-Month Beta -7.29
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/08/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1352 +262.43%
on 10/10/17
0.5200 -5.77%
on 10/11/17
+0.3400 (+226.67%)
since 09/20/17
3-Month
0.0470 +942.55%
on 08/16/17
0.5200 -5.77%
on 10/11/17
+0.4300 (+716.67%)
since 07/20/17
52-Week
0.0200 +2,350.00%
on 11/15/16
0.5200 -5.77%
on 10/11/17
+0.4000 (+444.44%)
since 10/19/16

Most Recent Stories

More News
Pivot Pharma Executes Binding Letter of Intent to Acquire ACI Foods Inc.

New acquisition generates annual revenue of CAD $2M from hemp-based product sales

PVOTF : 0.4900 (-3.92%)
Pivot Pharma Executes Binding Letter of Intent to Acquire ACI Foods Inc.

New acquisition generates annual revenue of CAD $2M from hemp-based product sales

PVOTF : 0.4900 (-3.92%)
The Biggest Problem Facing Cannabinoid Therapies and the Company That is Doubling Down on Solutions -- CFN Media

SEATTLE, WA--(Marketwired - Oct 2, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Pivot...

PVOTF : 0.4900 (-3.92%)
The Biggest Problem Facing Cannabinoid Therapies and the Company That is Doubling Down on Solutions -- CFN Media

SEATTLE, WA--(Marketwired - Oct 2, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Pivot...

PVOTF : 0.4900 (-3.92%)
Pivot Pharma and Solmic Research GmbH Sign License and Collaboration Agreement for Improved Oral Formulations of Cannabinoids

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (Pivot or the Company) and its medical cannabis product division, Pivot Green Stream Health Solutions, today announce the signing of a Definitive Agreement with...

PVOTF : 0.4900 (-3.92%)
Pivot Pharma and Solmic Research GmbH Sign License and Collaboration Agreement for Improved Oral Formulations of Cannabinoids

VANCOUVER, BC--(Marketwired - Sep 25, 2017) - Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (Pivot or the Company) and its medical cannabis product division, Pivot Green Stream Health Solutions, today announce...

PVOTF : 0.4900 (-3.92%)
Pivot Pharma and Solmic Research GmbH Sign License and Collaboration Agreement for Improved Oral Formulations of Cannabinoids

VANCOUVER, BC--(Marketwired - Sep 25, 2017) - Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (Pivot or the Company) and its medical cannabis product division, Pivot Green Stream Health Solutions, today announce...

PVOTF : 0.4900 (-3.92%)
Pivot Pharma Looks to Improve Cannabinoid Bioavailability with Topical BiPhasix(TM) Delivery System -- CFN Media

SEATTLE, WA--(Marketwired - Sep 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining...

PVOTF : 0.4900 (-3.92%)
Pivot Pharma Looks to Improve Cannabinoid Bioavailability with Topical BiPhasix(TM) Delivery System -- CFN Media

SEATTLE, WA--(Marketwired - Sep 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining...

PVOTF : 0.4900 (-3.92%)
Pivot Pharmaceuticals Acquires BiPhasix™ Transdermal Drug Delivery Technology

Pivot Pharmaceuticals Acquires BiPhasix" Transdermal Drug Delivery Technology

PVOTF : 0.4900 (-3.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Support & Resistance

2nd Resistance Point 0.5653
1st Resistance Point 0.5277
Last Price 0.4900
1st Support Level 0.4147
2nd Support Level 0.3393

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart